Safety of an Infant Formula With Hydrolysed Protein in Term Infants

NACompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

August 31, 2021

Study Completion Date

October 27, 2021

Conditions
Growth
Interventions
OTHER

Intervention Group: Infant Formula with hydrolyzed protein

Infants will receive infant formula during the first 120 days of life with optional follow up until 180 days of life (intervention formula manufactured from extensively hydrolysed whey protein).

OTHER

Control Group: Infant Formula with intact protein

Infants will receive infant formula during the first 120 days of life with optional follow up until 180 days of life (control formula manufactured from intact cow's milk protein).

Trial Locations (1)

13589

Evangelisches Waldkrankenhaus Spandau, Berlin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Waldkrankenhaus Protestant Hospital, Spandau

OTHER

collaborator

Biofortis, Merieux NutriSciences

INDUSTRY

collaborator

HungaroTrial

UNKNOWN

lead

HiPP GmbH & Co. Vertrieb KG

INDUSTRY